Search

Your search keyword '"Lilly Research Laboratories"' showing total 278 results
Start Over Descriptor "Lilly Research Laboratories"
278 results on '"Lilly Research Laboratories"'

1. Event Brief of Q3 2024 Eli Lilly and Co Earnings Call - Final

Subjects
United States. Food and Drug Administration -- Evaluation, Eli Lilly and Co., Lilly Research Laboratories, Chairpersons, Pharmaceutical industry, Business, Verzenio (Medication) -- Evaluation, Mounjaro (Medication) -- Evaluation, Zepbound (Medication) -- Evaluation
Abstract

CORPORATE PARTICIPANTS . Joe Fletcher - Eli Lilly and Co,Senior Vice President of Investor Relations . David Ricks - Eli Lilly and Co,Chairman of the Board, President, Chief Executive Officer [...]

Published
2024

3. Lilly's muvalaplin lowered lipoproteina levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Risk factors, Heart diseases -- Risk factors, Lipoprotein A, Medical research, Adults, Medicine, Experimental
Abstract

2024 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Eli Lilly and Company (NYSE: LLY) announced positive Phase 2 results for muvalaplin, an investigational [...]

Published
2024

4. Lilly appoints Lucas Montarce as executive vice president and chief financial officer

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry
Abstract

ENPNewswire-September 10, 2024--Lilly appoints Lucas Montarce as executive vice president and chief financial officer (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 09092024 - INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) [...]

Published
2024

5. Lilly opens state-of-the-art research and development center in the Boston Seaport

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Diabetes therapy, Ports, Industrial research -- United States, Pharmaceutical industry, Research and development, General interest, News, opinion and commentary
Abstract

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) today announced the opening of the Lilly Seaport Innovation Center (LSC), a research [...]

Published
2024

7. Studies from Lilly Research Laboratories Yield New Data on Antibodies (Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules)

Subjects
Lilly Research Laboratories, Case studies, Physical fitness -- Case studies, Fc receptors -- Case studies, Antibodies -- Case studies, Pharmaceutical industry -- Case studies, Viral antibodies -- Case studies
Abstract

2022 DEC 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on antibodies. According to news reporting out of [...]

Published
2022

8. Event Brief of Q1 2023 Eli Lilly and Co Earnings Call - Final

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Business, Jardiance (Medication), Trulicity (Medication), Verzenio (Medication), Mounjaro (Medication)
Abstract

CORPORATE PARTICIPANTS . Anat Ashkenazi - Eli Lilly and Company,Executive VP & CFO . Anne E. White - Eli Lilly and Company,EVP & President of Lilly Neuroscience . Daniel M. [...]

Published
2023

9. Lilly to Participate in Evercore ISI HealthCONx Conference

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry
Abstract

ENPNewswire-November 15, 2023--Lilly to Participate in Evercore ISI HealthCONx Conference (C)2023 ENPublishing - http://www.enpublishing.co.uk Release date- 14112023 - INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) will attend the sixth [...]

Published
2023

11. Research from Lilly Research Laboratories in Angiogenic Proteins Provides New Insights (Decoding the role of angiopoietin-like protein 4/8 complex-mediated plasmin generation in the regulation of LPL activity)

Subjects
Lilly Research Laboratories, Fibrinolytic agents, Pharmaceutical industry, Lipoprotein lipase, Proteins, Thrombolytic drugs
Abstract

2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Investigators publish new report on angiogenic proteins. According to news reporting out of Indianapolis, [...]

Published
2023

12. Eli Lilly participates in a conference call with Guggenheim

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Medical offices, Business, News, opinion and commentary
Abstract

Conference call with Chief Scientific & Medical Office and President of Lilly Research Laboratories, Dr. Skovronsky, who will discuss the Company's global strategy and innovation on June 18 at 11 [...]

Published
2021

13. Empyrean Neuroscience Forms Scientific Advisory Board

Subjects
United States. National Institute of Mental Health, Lilly Research Laboratories, Nervous system diseases, Hospitals -- United States, Mental health, Genetic engineering, Genetically modified organisms, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

NEW YORK & CAMBRIDGE, England: EMPYREAN NEUROSCIENCE, INC. has issued the following news release: Empyrean Neuroscience, Inc., a genetic engineering company dedicated to developing neuroactive compounds to treat neuropsychiatric and [...]

Published
2022

14. Empyrean Neuroscience Forms Scientific Advisory Board

Subjects
United States. National Institute of Mental Health, Lilly Research Laboratories, Homeopathy -- Materia medica and therapeutics, Nervous system diseases, Mental health, Therapeutics, Genetic engineering, Medical colleges, Genetically modified organisms, Business, Business, international
Abstract

--Company adds leading neuroscience experts with decades of experience in industry, at the National Institute of Mental Health, and in clinical practice-- --Board to advise on company's R&D of genetically [...]

Published
2022

15. Studies from Lilly Research Laboratories Update Current Data on Molecular Pharmaceuticals (Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems)

Subjects
Lilly Research Laboratories, Silicon dioxide, Physical fitness, Drugs, Pharmaceutical industry
Abstract

2020 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Biotechnology - Molecular Pharmaceuticals have been published. According [...]

Published
2020

16. Eli Lilly to provide drive-through COVID-19 testing for healthcare workers

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Workers, Health care industry, Medical personnel, Pharmaceutical industry, Time, Hospitals, Health care industry, Business, News, opinion and commentary
Abstract

Eli Lilly will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area health care workers beginning Monday, March 23, as a service to the community and [...]

Published
2020

17. Enveda Biosciences Welcomes Mark Deeg, M.D., Ph.D., as Chief Medical Officer

Subjects
Lilly Research Laboratories, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

BOULDER, Colo.: Enveda Biosciences announced the appointment of Mark Deeg, M.D., Ph.D., as the company's Chief Medical Officer. Dr. Deeg is a medical and pharmaceutical leader with broad experience developing [...]

Published
2022

18. Empyrean Neuroscience Forms Scientific Advisory Board

Subjects
United States. National Institute of Mental Health, Lilly Research Laboratories, Nervous system diseases, Hospitals, Mental health, Genetic engineering, Genetically modified organisms, Business, Business, international, Telecommunications industry
Abstract

Empyrean Neuroscience, a genetic engineering company dedicated to developing neuroactive compounds to treat neuropsychiatric and neurologic disorders, recently reported its scientific advisory board. Empyrean noted the board is composed of [...]

Published
2023

19. Studies from Lilly Research Laboratories Provide New Data on Nanoparticles (High-throughput profiling of antibody self-association in multiple formulation conditions by PEG stabilized self-interaction nanoparticle spectroscopy)

Subjects
Lilly Research Laboratories, Nanoparticles, Spectroscopy, Antibodies, Pharmaceutical industry, Viral antibodies, Spectrum analysis
Abstract

2022 DEC 12 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- A new study on nanoparticles is now available. According to news reporting out of [...]

Published
2022

20. Reports Outline Immunoglobulins Study Results from Lilly Research Laboratories (Antibody Conjugates-Recent Advances and Future Innovations)

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Physical fitness, Monoclonal antibodies, Pharmaceutical industry, Immunoglobulins, Antibodies, Therapeutics, Editors
Abstract

2020 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Immunology - Immunoglobulins have been published. According to [...]

Published
2020

22. FDA Approves New Antibody Drug to Fight Omicron Variant

Subjects
United States. Food and Drug Administration, Lilly Research Laboratories, Biopharmaceutics, Drug approval, Monoclonal antibodies, Pharmaceutical industry, News, opinion and commentary, Sports and fitness
Abstract

FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the omicron variant. [...]

Published
2022

23. FDA Approves New Antibody Drug to Fight Omicron Variant

Author

Thompson, Dennis

Subjects
United States. Food and Drug Administration, Lilly Research Laboratories, Biopharmaceutics, Drug approval, Monoclonal antibodies, Pharmaceutical industry, News, opinion and commentary, Sports and fitness
Abstract

Byline: Dennis Thompson FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against [...]

Published
2022

25. Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

Author

Small, David S., Farid, Nagy A., Payne, Christopher D., Weerakkody, Govinda J., Li, Ying G., Brandt, John T., Salazar, Daniel E., and Winters, Kenneth J.

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Dosage and administration, Drug interactions -- Dosage and administration, Metabolites, Platelet aggregation inhibitors -- Dosage and administration, Pharmaceutical industry, Health maintenance organizations, Lansoprazole -- Dosage and administration, Blood platelets -- Aggregation
Abstract

Keywords: Clopidogrel; prasugrel; lansoprazole; drug interaction 475 Drug InteractionsEffects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel SAGE Publications, Inc.200810.1177/0091270008315310 David S.Small PhD [...]

Published
2008
Full Text
View/download PDF

26. Patient-centric sampling special focus issue

Author

Melanie Anderson, Neil Spooner, and Enaksha R Wickremsinhe

Subjects
2019-20 coronavirus outbreak, Blood Specimen Collection, Coronavirus disease 2019 (COVID-19), business.industry, Clinical Biochemistry, Library science, General Medicine, Analytical Chemistry, Clinical trial, Medical Laboratory Technology, Patient centric, Health care, Humans, Sampling (medicine), General Pharmacology, Toxicology and Pharmaceutics, business, Lilly Research Laboratories, Blood sampling
Abstract

[ ]of writing, it is unclear whether this will result in a permanent change in how blood sampling for clinical trials and routine healthcare are performed, although it seems unlikely that the progression of these sampling technologies will be slowed by the current situation Many of the early publications in this area had a primary focus on the development of blood sampling technologies, validation of bioanalytical methods and were limited to applications supporting nonclinical and clinical studies for pharmaceutical drug development Bioanalysis 7(16) (2015) https://www future-science com/toc/bio/7/16 Neil Spooner: Spooner Bioanalytical Solutions Ltd, Hertford, UK and School of Life and Medical Sciences, University of Hertfordshire, UK Melanie Anderson: Merck and Co , Inc , West Point, PA 19486, USA Enaksha R Wickremsinhe: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA

Published
2020

27. TB Alliance welcomes Jan Lundberg to board

Subjects
Eli Lilly and Co., AstraZeneca PLC, Lilly Research Laboratories, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Global Banking News-January 16, 2019-TB Alliance welcomes Jan Lundberg to boardTuberculosis drug company TB Alliance revealed on Tuesday the addition of Jan Lundberg to its board of directors.Dr Lundberg spent [...]

Published
2019

28. Eli Lilly participates in a conference call with Bernstein

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

Bernstein Pharmaceuticals Analyst Anderson hosts Executive Vice President of Lilly Research Laboratories, Jan Lundberg, who provides an update on pivotal Phase 3 pipeline drugs, Baricitinib, Tanezumab, Lasmidtan and Galcanezumab on [...]

Published
2018

29. Lilly Research Laboratories Researchers Provide New Data on Immunoglobulins (An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif)

Subjects
Lilly Research Laboratories, Fatty acids, Amino acids, Antibodies, Pharmaceutical industry, Triglycerides, DNA binding proteins, Viral antibodies
Abstract

2022 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Fresh data on immunoglobulins are presented in a new report. According to news reporting [...]

Published
2022

30. Lilly to Participate in Guggenheim Biopharma Strategy Series

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Biological products industry, Pharmaceutical industry, General interest, News, opinion and commentary
Abstract

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series - Biopharma's Next Decade: Views [...]

Published
2021

31. Lilly to Participate in Guggenheim Biopharma Strategy Series

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Biological products industry, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series -- Biopharma's Next Decade: Views from the Top on Global [...]

Published
2021

32. Slone Partners Places Sotirios Karathanasis as Chief Science Officer at Enveda Biosciences

Subjects
Lilly Research Laboratories, Drug discovery, Biotechnology industry, Employment services, Pharmaceutical industry, Business, international, Law
Abstract

(PRWeb) - Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer [...]

Published
2021

33. Slone Partners Places Sotirios Karathanasis as Chief Science Officer at Enveda Biosciences

Subjects
Lilly Research Laboratories, Drug discovery, Biotechnology industry, Employment services, Pharmaceutical industry, Business, general
Abstract

SOUTH RIDING, Va. (PRWEB) April 29, 2021 Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as [...]

Published
2021

34. AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation Join the Access to Comprehensive Genomic Profiling Coalition

Subjects
AstraZeneca PLC, Lilly Research Laboratories, Health insurance industry, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

WASHINGTON, April 19, 2021 /PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation (NYSE: NVTA) to [...]

Published
2021

35. Eli Lilly and Company - Lilly to Participate in Cowen Health Care Conference

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry
Abstract

ENPNewswire-February 25, 2021--Eli Lilly and Company - Lilly to Participate in Cowen Health Care Conference (C)2021 ENPublishing - http://www.enpublishing.co.uk Release date- 24022021 - INDIANAPOLIS - Eli Lilly and Company (NYSE: [...]

Published
2021

36. Eli Lilly and Company - Lilly Appoints Anat Ashkenazi Chief Financial Officer

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry
Abstract

ENPNewswire-February 10, 2021--Eli Lilly and Company - Lilly Appoints Anat Ashkenazi Chief Financial Officer (C)2021 ENPublishing - http://www.enpublishing.co.uk Release date- 09022021 - INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) [...]

Published
2021

37. 8-K: ELI LILLY & Co

Subjects
United States. Securities and Exchange Commission, Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Business, general
Abstract

(EDGAR Online via COMTEX) -- ELI LILLY & Co false 0000059478 --12-31 0000059478 2021-02-09 2021-02-09 0000059478 us-gaap:CommonClassAMember 2021-02-09 2021-02-09 0000059478 lly:A1.000NotesDueJune22022Member 2021-02-09 2021-02-09 0000059478 lly:A718NotesDueJune12025Member 2021-02-09 2021-02-09 0000059478 lly:A1.625NotesDueJune22026Member 2021-02-09 [...]

Published
2021

38. Lilly's antibody could reduce COVID-19 risk by 80%, trial shows

Subjects
United States. National Institutes of Health, United States. National Institute of Allergy and Infectious Diseases, Lilly Research Laboratories, Viral antibodies, Antibodies, Nursing homes, Pharmaceutical industry, Business, international, Law
Abstract

The Phase III BLAZE-2 COVID-19 prevention trial conducted in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the [...]

Published
2021

39. FDA authorizes Covid-19 antibody treatment for emergency use

Author

Long, Samantha

Subjects
United States. Food and Drug Administration, Lilly Research Laboratories, Monoclonal antibodies -- Health aspects, Pharmaceutical industry -- Health aspects, COVID-19 -- Development and progression, News, opinion and commentary, Sports and fitness
Abstract

Byline: Samantha Long However, for patients with a high risk of disease progression, hospitalisation and accident and emergency (A&E) visits occurred in 3% of bamlanivimab-treated patients compared to 10% of [...]

Published
2020

41. Lilly starts trials of potential coronavirus treatment

Subjects
Lilly Research Laboratories, Clinical trials, Coronaviruses, Antibodies, Pharmaceutical industry, Biological products, Time, Scientists, Biopharmaceuticals, Diseases, Business, international, Law
Abstract

Eli Lilly and Co. has embarked on trials of the first potential new antibody drug to treat COVID-19, the illness caused by the coronavirus. Delivered in a one-time dose through [...]

Published
2020

42. Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Workers -- Health aspects, Health care industry -- Health aspects, Medical personnel -- Health aspects, Pharmaceutical industry -- Health aspects, Hospitals, Health care industry, General interest, News, opinion and commentary
Abstract

INDIANAPOLIS: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area [...]

Published
2020

43. Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry
Abstract

ENPNewswire-March 23, 2020--Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers (C)2020 ENPublishing - http://www.enpublishing.co.uk Release date- 22032020 - Eli Lilly and Company (NYSE:LLY) will offer drive-through testing [...]

Published
2020

44. Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers

Subjects
Eli Lilly and Co., Lilly Research Laboratories, Workers, Health care industry, Medical personnel, Pharmaceutical industry, Health care industry, Business, News, opinion and commentary
Abstract

INDIANAPOLIS, March 22, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area health care workers beginning Monday, [...]

Published
2020

45. Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories

Subjects
United States. Department of State, United States. Food and Drug Administration, Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Scientists, Media executives, Chairpersons, General interest, News, opinion and commentary
Abstract

Indianapolis: Eli Lilly and Company has issued the following press release: Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), [...]

Published
2020

46. Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories

Subjects
United States. Department of State, United States. Food and Drug Administration, Eli Lilly and Co., Lilly Research Laboratories, Pharmaceutical industry, Business, News, opinion and commentary
Abstract

INDIANAPOLIS, March 18, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), with support from the Food [...]

Published
2020

47. Investigators at Oregon Health and Science University Zero in on Osteogenesis Imperfecta (Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy)

Subjects
Lilly Research Laboratories, Oregon Health & Science University, Research, Bone density -- Research, Physical fitness -- Research, Osteogenesis imperfecta -- Research, Teriparatide -- Research, Medical research, Pharmaceutical industry -- Research, Adults -- Research, Medicine, Experimental, Bones -- Density
Abstract

2017 DEC 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Musculoskeletal Diseases and Conditions - Osteogenesis Imperfecta have [...]

Published
2017

48. Safety in numbers

Author

Ramesh Durvasula

Subjects
Officer, Engineering, Computer Networks and Communications, Hardware and Architecture, business.industry, business, Safety in numbers, Lilly Research Laboratories, Software, Management
Abstract

This is a guest editorial by Ramesh Durvasula, information officer for research at Lilly Research Laboratories. It is adapted from the article “Safety in Numbers: Connecting the Community to Improv...

Published
2021
Full Text
View/download PDF

49. Lilly Research Laboratories Researchers Highlight Recent Research in Mycobacterium tuberculosis (Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis)

Subjects
Lilly Research Laboratories, Pharmaceutical industry, Tuberculosis
Abstract

2021 MAY 17 (NewsRx) -- By a News Reporter-Staff News Editor at Tuberculosis Week -- Data detailed on Mycobacterium tuberculosis have been presented. According to news originating from Indianapolis, Indiana, [...]

Published
2021

50. Event Brief of Q3 2017 Eli Lilly and Co Earnings Call - Final

Subjects
United States. Food and Drug Administration, Novartis AG, Eli Lilly and Co., Barclays PLC, Sanofi S.A., Lilly Research Laboratories, Financial services, Pharmaceutical industry, Financial services industry, Business, Jardiance (Medication), Basaglar (Medication), Trulicity (Medication), Forteo (Medication), Verzenio (Medication), Taltz (Medication), Humalog (Medication)
Abstract

CORPORATE PARTICIPANTS . Christi Shaw - Eli Lilly and Company,SVP and President of Lilly Bio-Medicines . David A. Ricks - Eli Lilly and Company,Chairman, CEO & President . Derica W. [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results